Trailing-twelve-month (TTM) revenue is $456.21 Million with a year-over-year growth of +3.83%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $114,198,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-31 |
| Q4 FY2025Period ended 2025-12-31 | $116,729,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-10 |
| Q1 FY2026Period ended 2026-03-31 | $109,177,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-05 |
| Q2 FY2026Period ended 2026-06-30 | $116,102,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $456,206,000 |
Current P/S: $358,184,798 market capitalization ÷ $456,206,000 TTM revenue = 0.79x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T14:50:59.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $116.10M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:21:45.829Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2022-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2021-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20172017-12-31 · USD | FY20182018-12-31 · USD | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD |
|---|---|---|---|---|---|---|
| Commercial Lines Segment | $358M | $218M | N/A | N/A | N/A | N/A |
| Commercial Specialty Segment | N/A | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20162016-12-31 · USD | FY20172017-12-31 · USD | FY20182018-12-31 · USD | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD |
|---|---|---|---|---|---|---|
| Non U S Subsidiaries | $261M | $258M | $185M | $108M | $67M | $0 |
| United States Subsidiaries | $308M | $270M | $345M |
$456.21M
$456.21 Million
+3.83%
vs. $439.38M a year ago (TTM)
(6.56%)
5 Year compound annual growth rate
1 Year
+3.83%
3 Year
(10.81%)
5 Year
(6.56%)
10 Year
(1.05%)
15 Year
+1.03%
20 Year
(1.27%)
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $450.10M | +$8.91M | +2.02% |
| 2024 | $441.19M | ($86.94M) | (16.46%) |
| 2023 | $528.13M | ($100.41M) | (15.97%) |
| 2022 | $628.53M | ($49.73M) | (7.33%) |
| 2021 | $678.27M | +$94.72M | +16.23% |
| 2020 |
TTM Growth
+3.83%
3-Year CAGR
(10.81%)
5-Year CAGR
(6.56%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $238M |
| $286M |
| $340M |
| $378M |
| Exited Lines Segment | N/A | N/A | N/A | N/A | $106M | $83M |
|---|
| Farm Ranch And Stable Segment | N/A | N/A | $71M | $76M | $72M | N/A |
|---|
| Personal Lines Segment | $438M | $198M | N/A | N/A | N/A | N/A |
|---|
| Reinsurance Operations | $87M | $51M | $76M | $75M | $78M | $141M |
|---|
| Specialty Property Segment | N/A | N/A | $140M | $133M | N/A | N/A |
|---|
| $526M |
| $678M |
| $583.55M |
| ($20.93M) |
| (3.46%) |
| 2019 | $604.47M | +$105.53M | +21.15% |
| 2018 | $498.94M | +$13.42M | +2.76% |
| 2017 | $485.51M | ($49.00M) | (9.17%) |
| 2016 | $534.51M | ($4.26M) | (0.79%) |
